← Back to Conditions
WARS2-related combined oxidative phosphorylation defect
disorderSNOMED 1260128008CUI C4540192
Overview
WARS2-related combined oxidative phosphorylation defect is a disorder.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Delayed CNS myelination
Always present (100%)HP:0002188
Difficulty articulating speech
Always present (100%)HP:0001260
Diffuse cerebral atrophy
Always present (100%)HP:0002506
Increased length of philtrum
Always present (100%)HP:0000343
Low blood sugar
Always present (100%)HP:0001943
Severe temper tantrums
Always present (100%)HP:0025162
Abnormality of movement
Very frequent (80-99%)HP:0100022
Hypotonia, early
Very frequent (80-99%)HP:0008947
Mental deficiency
Very frequent (80-99%)HP:0001249
Psychomotor development deficiency
Very frequent (80-99%)HP:0001263
Abnormal circulating enzyme concentration or activity
Frequent (30-79%)HP:0012379
Abnormal vocalization
Frequent (30-79%)HP:0002167
Abnormality of the periventricular white matter
Frequent (30-79%)HP:0002518
Appendicular hypertonia
Frequent (30-79%)HP:0002509
Cerebral white matter hypoplasia
Frequent (30-79%)HP:0012430
Degeneration of cerebellum
Frequent (30-79%)HP:0001272
Delayed myelination
Frequent (30-79%)HP:0012448
Dilated cerebral ventricle
Frequent (30-79%)HP:0002119
Epilepsy
Frequent (30-79%)HP:0001250
Gait disturbance
Frequent (30-79%)HP:0001288
Increased blood lactate
Frequent (30-79%)HP:0002151
Increased reflexes
Frequent (30-79%)HP:0001347
Lacticacidosis
Frequent (30-79%)HP:0003128
Limb dystonia
Frequent (30-79%)HP:0002451
Moderate mental retardation
Frequent (30-79%)HP:0002342
Muscle atrophy, generalised
Frequent (30-79%)HP:0003700
Muscle weakness
Frequent (30-79%)HP:0001324
physical aggression
Frequent (30-79%)HP:0000718
Small for gestational age infant
Frequent (30-79%)HP:0001511
Supratentorial atrophy
Frequent (30-79%)HP:0002059
Quick Facts
- SNOMED CT
- 1260128008
- UMLS CUI
- C4540192
- Fully Specified Name
- Tryptophanyl tRNA synthetase 2, mitochondrial-related combined oxidative phosphorylation defect (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 30
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.